HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, V. Articles by Criner, G. J. Search for Related Content PubMed PubMed Citation Articles by Kim, V. Articles by Criner, G. J.

New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease

¹ Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania

Correspondence and requests for reprints should be addressed to Victor Kim, M.D., Assistant Professor of Medicine, Temple University School of Medicine, 785 Parkinson Pavilion, 3401 North Broad Street, Philadelphia, PA 19140. E-mail: victor.kim{at}tuhs.temple.edu

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is characterized by an abnormal persistent inflammatory response to cigarette smoke. This noxious insult leads to emphysema and airway remodeling, manifested by squamous and mucous metaplasia of the epithelium, smooth muscle hypertrophy, and airway wall fibrosis. These pathologic abnormalities interact synergistically to cause progressive airflow obstruction. Although it has been accepted that the spectrum of COPD is vast, the reasons for the development of different phenotypes from the same exposure to cigarette smoke have not been determined. Furthermore, it is becoming increasingly clear that airways disease and emphysema often coexist in many patients, even with a clear clinical phenotype of either emphysema or chronic bronchitis. Recent studies have focused on the nature of the inflammatory response to cigarette smoke, the inflammatory cell lines responsible for COPD pathogenesis, and new biomarkers for disease activity and progression. New cytokines are being discovered, and the complex interactions among them are being unraveled. The inflammatory biomarker that has received the most attention is C-reactive protein, but new ones that have caught our attention are interleukin (IL)-6, tumor necrosis factor-, IL-8, and IL-10. Further research should focus on how these new concepts in lung inflammation interact to cause the various aspects of COPD pathology.

Key Words: chronic obstructive pulmonary disease • pathology • airway inflammation • emphysema • inflammatory biomarkers

This article has been cited by other articles:

				F. M. Botelho, G. J. Gaschler, S. Kianpour, C. C. J. Zavitz, N. J. Trimble, J. K. Nikota, C. M. T. Bauer, and M. R. Stampfli Innate Immune Processes Are Sufficient for Driving Cigarette Smoke-Induced Inflammation in Mice Am. J. Respir. Cell Mol. Biol., April 1, 2010; 42(4): 394 - 403. [Abstract] [Full Text] [PDF]

				M. Broekema, N. H. T. ten Hacken, F. Volbeda, M. E. Lodewijk, M. N. Hylkema, D. S. Postma, and W. Timens Airway Epithelial Changes in Smokers but Not in Ex-Smokers with Asthma Am. J. Respir. Crit. Care Med., December 15, 2009; 180(12): 1170 - 1178. [Abstract] [Full Text] [PDF]

				C. J. Jolley and J. Moxham A physiological model of patient-reported breathlessness during daily activities in COPD Eur. Respir. Rev., June 1, 2009; 18(112): 66 - 79. [Abstract] [Full Text] [PDF]

				T. Walser, X. Cui, J. Yanagawa, J. M. Lee, E. Heinrich, G. Lee, S. Sharma, and S. M. Dubinett Smoking and Lung Cancer: The Role of Inflammation Proceedings of the ATS, December 1, 2008; 5(8): 811 - 815. [Abstract] [Full Text] [PDF]